Bal Pharma Ltd Share Price
(BALPHARMA)
₹97.48▲3.53%
as on 04:02PM, 21 Feb 2025
Bal Pharma Ltd Performance
Day's Low
Day's High
₹94.89Day's Price Range₹97.9552 Week's Low
52 Week's High
₹88.9552-Week Price Range₹157.98
| Returns % | |
| 1 Month Return | -9.97 % |
| 3 Month Return | -28.92 % |
| 1 Year Return | -17.11 % |
| Market Stats | |
| Previous Close | ₹94.16 |
| Open | ₹95.00 |
| Volume | 12.69K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹149.91Cr |
Bal Pharma Ltd Key Statistics
P/E Ratio
19.33
PEG Ratio
7.38
Market Cap
₹149.91 Cr
P/B Ratio
1.37
EPS
4.71
Dividend Yield
1.31
Sector
Pharmaceuticals
ROE
10.19
Key events for Bal Pharma Ltd
Bal Pharma Ltd's Low P/E Ratio May Indicate Limited Growth Expectations - 30 May, 2024
Investors may be expecting limited growth rates for Bal Pharma Ltd, resulting in a low P/E ratio of 25.5x. While the company has seen rapid earnings growth in the past year and three-year period, its medium-term trajectory is expected to lag behind the broader market's forecasted expansion.Bal Pharma Q4 FY24 Net Profit Jumps to Rs 5.53 Crore - 29 May, 2024
Bal Pharma's consolidated net profit for Q4 FY24 stood at Rs 5.53 crore, up from Rs 1.61 crore in Q4 FY23. The company's board has declared a dividend of Rs 1.20 per equity share. Bal Pharma stock locked in an upper circuit of 20%.
Insights on Bal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 73.49 Cr → 73.66 Cr (in ₹), with an average increase of 0.2% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.13% to 0.14% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 57.9% return, outperforming this stock by 75.0%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.1% return, outperforming this stock by 128.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.86% of holdings in Dec 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 1.04 Cr → 0.48 Cr (in ₹), with an average decrease of 53.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 49.01% to 49.00% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, BALPHARMA stock has moved down by -28.9%
Bal Pharma Ltd Financials
Bal Pharma Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.86% | 0.00 | |
| Foreign Institutions | 0.14% | 4.34 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49% | ||
| Others | 0% | 0.00 |
Bal Pharma Ltd Key Indicators
Bal Pharma Ltd Valuation
Bal Pharma Ltd in the last 5 years
Lowest (-535.88x)
June 15, 2018
Today (19.33x)
February 20, 2025
Industry (51.76x)
February 20, 2025
Highest (203.65x)
September 12, 2018
Bal Pharma Ltd Earnings and Dividends
Bal Pharma Ltd Earnings Results
Bal Pharma Ltd’s net profit fell -46.07% since last year same period to ₹0.48Cr in the Q3 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated -53.85% fall in its net profits since last 3-months.
Read More about Earnings ResultsBal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 2.26%.
Read More about Dividends
Bal Pharma Ltd Technicals Summary
Bearish
Neutral
Bullish
Bal Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Bal Pharma Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹149.91 Cr | 31.85% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹181.11 Cr | -3.44% | 0.96 | NA | NA | |
| NA | ₹42.63 Cr | 6.79% | 0.58 | NA | NA | |
| NA | ₹2,091.41 Cr | 42.75% | 0.65 | -₹2 Cr | ₹559 Cr | |
| NA | ₹1,130.58 Cr | 43.88% | 0.50 | ₹93 Cr | ₹580 Cr |
About Bal Pharma Ltd
Share Price: ₹97.48 per share as on 21 Feb, 2025 04:02 PM
Market Capitalisation: ₹149.91Cr as of today
Revenue: ₹73.15Cr as on December 2024 (Q4 24)
Net Profit: ₹0.52Cr as on December 2024 (Q4 24)
Listing date: 08 May, 2006
| Organisation | Bal Pharma Ltd |
| Headquarters | Bangalore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Bal Pharma Ltd
What is Bal Pharma Ltd price today?
Bal Pharma Ltd share price today stands at ₹97.48, Open: ₹95, Previous Close: ₹94.16, High: ₹97.95, Low: ₹94.89, 52 Week High: ₹157.98, 52 Week Low: ₹88.95.
How to Buy Bal Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Bal Pharma Ltd shares
Is Bal Pharma Ltd listed on NSE?
Bal Pharma Ltd is listed on NSE
Is Bal Pharma Ltd listed on BSE?
Bal Pharma Ltd is listed on BSE
What are today's High and Low prices of Bal Pharma Ltd?
- Today's highest price of Bal Pharma Ltd is ₹97.95.
- Today's lowest price of Bal Pharma Ltd is ₹94.89.
What are today's traded volumes of Bal Pharma Ltd?
Today's traded volume of Bal Pharma Ltd(BALPHARMA) is 12.69K.
What is today's market capitalisation of Bal Pharma Ltd?
Today's market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹149.91Cr.
What is the 52 Week High and Low Range of Bal Pharma Ltd?
How much percentage Bal Pharma Ltd is down from its 52 Week High?
Bal Pharma Ltd (BALPHARMA) share price is ₹97.48. It is down -38.30% from its 52 Week High price of ₹157.98
How much percentage Bal Pharma Ltd is up from its 52 Week low?
Bal Pharma Ltd (BALPHARMA) share price is ₹97.48. It is up 9.59% from its 52 Week Low price of ₹88.95
What are the historical returns of Bal Pharma Ltd?
What is the PE ratio of Bal Pharma Ltd today?
PE Ratio of Bal Pharma Ltd is 19.33
PE ratio = Bal Pharma Ltd Market price per share / Bal Pharma Ltd Earnings per share